• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kura Oncology (NQ: KURA )

    21.03 +0.28 (+1.35%)
    Streaming Delayed Price Updated: 10:29 AM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 81,909
    Open 20.65
    Bid (Size) 21.00 (1)
    Ask (Size) 21.07 (8)
    Prev. Close 20.75
    Today's Range 20.48 - 21.24
    52wk Range 7.410 - 24.17
    Shares Outstanding 68,438,576
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
    Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. 
    Via InvestorPlace
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END 
    Via FinancialNewsMedia

    Performance

    YTD
    +36.91%
    +36.91%
    1 Month
    -0.24%
    -0.24%
    3 Month
    +15.61%
    +15.61%
    6 Month
    +50.21%
    +50.21%
    1 Year
    +104.97%
    +104.97%

    More News

    Read More
    2 Incredible Growth Stocks to Buy Hand Over Fist
    Via The Motley Fool
    Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6
    Via Investor Brand Network
    Kura Oncology: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Earnings Outlook For Kura Oncology
    Via Benzinga
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    From FN Media Group LLC
    Via GlobeNewswire
    KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024
    Via InvestorPlace
    Kura Oncology Inc. (NASDAQ: KURA) Near the Top of Equities by Percentage Gain on 1/24
    Via Investor Brand Network
    A Preview Of Kura Oncology's Earnings
    Via Benzinga
    MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
    Via Talk Markets
    Kura Makes Good On Its $150 Million Infusion And Shoots Up Another 15%
    Via Investor's Business Daily
    Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Cancer-Drug Developer Kura Oncology Stock Is Up
    Via Benzinga
    General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Dow Edges Lower; US Composite PMI Rises In January
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?
    Via Benzinga
    Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Kura Oncology Rockets 39% Before Unveiling Cancer Drug Test Results — Here's Why
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.